Are we seeing changes in the rates of secondary blood-related cancers that develop due to chemotherapy or radiation?
Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
Are we seeing changes in the rates of secondary blood-related cancers that develop due to chemotherapy or radiation?
Diabetes drug, metformin, may echo the benefits of exercise in prostate cancer care
New study sheds light on evolving trends in oral cavity cancer among younger adults
New evidence that fat promotes tumour growth in aggressive breast cancer
Experimental dual-drug nanotherapy crosses the blood–brain barrier and improved survival in preclinical glioblastoma models
Study of robotic bronchoscopy suggests it's safer, faster path to diagnosing lung cancer
Common metabolic enzyme could predict cancer immunotherapy benefits, and help more patients respond
EU approval for pembrolizumab plus paclitaxel ± bevacizumab for adult PD-L1 platinum-resistant recurrent ovarian carcinoma
Pesticides and cancer: A study reveals the biological mechanisms behind an environmental health risk
New research reveals dangers of ‘anti-aging’ supplements in cancer protection
ASGCR 2026: Call for proposals and Pearline Award nominations
‘‘Smart’’ drugs to fight cancer